试剂批间差验证:实践挑战与多方协作
本文讨论了试剂批间差验证作为监测测量程序长期稳定性的重要组成部分,面临资源需求和实验设计与统计分析不确定性的挑战。协作验证和基于患者的监测有助于及时识别性能差异,失败验证的后续处理需平衡临床服务中断。制造商应提高放行标准透明度,监管机构、制造商和检验专业机构三方协作对确保患者安全至关重要。
要点
- 试剂批间差验证是监测测量程序长期稳定性的必要环节。
- 协作验证与基于患者的监测可更及时发现批间性能差异。
- 失败验证的后续处理需平衡对临床服务的潜在影响。
核心结论
- 试剂批间差验证是监测测量程序长期稳定性的必要环节,需平衡资源、实验设计与统计分析。
- 协作验证和基于患者的监测有助于更及时识别批间性能差异。
- 监管机构、制造商和检验专业机构的三方协作对减少批间差异和确保患者安全至关重要。
研究设计与样本
- 本文为来自Clinical Chemistry and Laboratory Medicine的综述/观点文章,讨论试剂批间差验证的实践挑战与多方协作。
主要发现
- 试剂批间差验证面临资源需求以及实验设计和统计分析不确定性的挑战。
- 协作验证和基于患者的监测可能进一步改善对性能差异的及时识别。
- 制造商需提高放行标准的透明度,并与检验专业人员更紧密合作。
临床怎么用
- 实验室应开展试剂批间差验证以监测测量程序的长期稳定性。
- 可考虑协作验证和基于患者的监测以辅助识别批间性能差异。
- 对失败验证需采取适当后续措施,并平衡对临床服务的潜在影响。
局限性
- 本文未报告具体的实验设计、统计分析方法或验证数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lot-to-lot verification is an integral component for monitoring the long-term stability of a measurement procedure. The practice is challenged by the resource requirements as well as uncertainty surrounding experimental design and statistical analysis that is optimal for individual laboratories, although guidance is becoming increasingly available. Collaborative verification efforts as well as application of patient-based monitoring are likely to further improve identification of any differences in performance in a relatively timely manner. Appropriate follow up actions of failed lot-to-lot verification is required and must balance potential disruptions to clinical services provided by the laboratory. Manufacturers need to increase transparency surrounding release criteria and work closer with laboratory professionals to ensure acceptable reagent lots are released to end users. A tripartite collaboration between regulatory bodies, manufacturers, and laboratory medicine professional bodies is key to developing a balanced system where regulatory, manufacturing, and clinical requirements of laboratory testing are met, to minimize differences between reagent lots and ensure patient safety. Clinical Chemistry and Laboratory Medicine has served as a fertile platform for advancing the discussion and practice of lot-to-lot verification in the past 60 years and will continue to be an advocate of this important topic for many more years to come.
引用
- Loh TP, Markus C, Tan CH, et al. Lot-to-lot variation and verification. Clin Chem Lab Med. 2022. PMID: 36420533. doi:10.1515/cclm-2022-1126
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。